TickerFacts.

A business in context

VRTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-10-20 · 0000875320-26-000278 · Items 5.02

  2. 4 · Ownership change

    Report date 2026-10-15 · 0000875320-26-000276

  3. 4 · Ownership change

    Report date 2026-10-15 · 0000875320-26-000274

  4. 4 · Ownership change

    Report date 2026-09-08 · 0000875320-26-000272

  5. 4 · Ownership change

    Report date 2026-08-28 · 0000875320-26-000267

  6. 8-K · Current report

    Report date 2026-08-27 · 0000875320-26-000264 · Items 5.02

  7. 4 · Ownership change

    Report date 2026-08-27 · 0000875320-26-000261

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000875320-26-000259

  9. 8-K · Current report

    Report date 2026-08-03 · 0000875320-26-000256 · Items 2.02,9.01

  10. 4 · Ownership change

    Report date 2026-07-21 · 0000875320-26-000253

  11. 4 · Ownership change

    Report date 2026-07-21 · 0000875320-26-000251

  12. 4 · Ownership change

    Report date 2026-07-15 · 0000875320-26-000249

  13. 8-K · Current report

    Report date 2026-07-06 · 0001193125-26-296710 · Items 1.01,7.01,8.01,9.01

  14. 8-K · Current report

    Report date 2026-05-13 · 0000875320-26-000204 · Items 5.02,5.07

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000875320-26-000173

  16. 8-K · Current report

    Report date 2026-05-04 · 0000875320-26-000171 · Items 2.02,9.01

  17. 8-K · Current report

    Report date 2026-04-28 · 0000875320-26-000166 · Items 5.02

  18. DEF 14A · Proxy statement

    Report date 2026-05-13 · 0000875320-26-000153

  19. 8-K · Current report

    Report date 2026-03-31 · 0000875320-26-000147 · Items 8.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0000875320-26-000056

  21. 8-K · Current report

    Report date 2026-02-12 · 0000875320-26-000034 · Items 2.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000875320-25-000232

  23. 8-K · Current report

    Report date 2025-11-03 · 0000875320-25-000230 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000875320-25-000216

  25. 8-K · Current report

    Report date 2025-08-04 · 0000875320-25-000213 · Items 2.02,5.02,9.01

  26. 8-K · Current report

    Report date 2025-05-19 · 0000875320-25-000199 · Items 8.01

  27. 8-K · Current report

    Report date 2025-05-14 · 0000875320-25-000194 · Items 5.07

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000875320-25-000192

  29. 8-K · Current report

    Report date 2025-05-05 · 0000875320-25-000171 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-05-14 · 0000875320-25-000160

  31. 8-K · Current report

    Report date 2025-03-28 · 0000875320-25-000156 · Items 8.01

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000875320-25-000053

  33. 8-K · Current report

    Report date 2025-02-04 · 0000875320-25-000029 · Items 2.02,5.02,9.01

  34. 8-K · Current report

    Report date 2024-12-20 · 0000875320-24-000231 · Items 7.01

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000875320-24-000223

  36. 8-K · Current report

    Report date 2024-11-04 · 0000875320-24-000221 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-08-15 · 0000875320-24-000207 · Items 1.01

  38. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000875320-24-000198

  39. 8-K · Current report

    Report date 2024-08-01 · 0000875320-24-000193 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2024-06-27 · 0000875320-24-000178 · Items 8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 3 transaction rows3SGrant / award: 6 transaction rows6AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 1 transaction rows1G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

10 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-10
van Grunsven JasperA · Grant / award
Acquired
Common Stock8682.00.0
2026-08-28
2026-09-01
Ambrose KristenA · Grant / award
Acquired
Common Stock5000.00.0
2026-08-27
2026-08-31
SACHS BRUCE IG · Gift
Disposed
Common Stock6000.00.0
2026-07-21
2026-07-23
Tatsis OuraniaA · Grant / award
Acquired
Common Stock8251.00.0
2026-07-21
2026-07-23
Sachdev AmitA · Grant / award
Acquired
Common Stock8251.00.0
2026-07-15
2026-07-17
SACHS BRUCE IA · Grant / award
Acquired
Deferred Stock Units
Derivative security
99.94475.28
2026-07-15
2026-07-17
Garber Alan MA · Grant / award
Acquired
Deferred Stock Units
Derivative security
31.56475.28
2026-07-02
2026-07-07
Tatsis Ourania
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1500.0524.99
2026-07-02
2026-07-07
McKechnie Duncan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1541.0519.0
2026-07-01
2026-07-06
Liu Joy
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock828.0502.71

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000875320VERTEX PHARMACEUTICALS INC / MA
Vertex Pharmaceuticals (United Kingdom)

Showing 1 of 1 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Vertex Pharmaceuticals · alias · wikidata
  • Vertex Pharmaceuticals Inc. · alias · wikidata
  • Vertex · alias · wikidata
  • Vertex Pharmaceuticals (United Kingdom) · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$11.02B$11.84B
2023-12-31$9.87B$10.91B
2022-12-31$8.93B$10.28B
2021-12-31$7.57B$9.42B
2020-12-31$6.21B$8.08B
2019-12-31$4.16B$5.49B
2018-12-31$3.05B$4.09B
2017-12-31$2.49B$3.42B

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗